GlaxoSmithKline reportedly is in talks with the U.K. government for a deal to supply flu vaccine for the entire country for use in a pandemic. GSK recently made similar agreements with Switzerland and Singapore and is close to signing a contract with France, even though the vaccine has not yet received regulatory clearance.

Related Summaries